Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
We presented two cases of Cryptococcus albidus fungemia in men who were identified with millary nodules by chest computed tomography (CT). They present cough and fever, with no other abnormal physical examination. The patients were treated successfully with a week-long course of voriconazole tablets. Accurate microbiological diagnosis of NGS and effective therapy as antifungal treatment of voriconazole tablet are critical for infection. Total of 18 cases of infection cases were identified from 2000 years to now, eight of which were invasive infection, and ten were noninvasive infection. None died cases were reported in noninvasive infection.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11263752 | PMC |
| http://dx.doi.org/10.1016/j.rmcr.2024.102054 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Biochemical characterization of lipase from Cryptococcus albidus (D24) and its application in sugar fatty acid ester synthesis.
Arch Microbiol
June 2025
Department of Functional Anatomy, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Microbial lipases are widely used in industrial applications. The lipase enzyme from Cryptococcus albidus (D24) strain was biochemically characterized and evaluated for its potential in catalyzing esterification reactions, particularly in the synthesis of sugar fatty acid esters. The enzyme demonstrated enhanced activity in solvents like acetone, isopropanol, and dimethylformamide.
View Article and Find Full Text PDFCryptococcus albidus meningitis: A case report and literature review.
Medicine (Baltimore)
April 2025
Beijing Electric Power Hospital of State Grid Co. of China, Capital Medical University Electric Teaching Hospital, Beijing, China.
Rationale: Central nervous system (CNS) infections caused by Cryptococcus albidus are rarely reported, but are often associated with high mortality rates. Clinical data on the appropriate use of liposomal-amphotericin B (liposomal-AmB) with cryptococcal meningitis are limited. Here, we report for the first time the efficacious and safe use of the ideal bodyweight to calculate the dose of liposomal-AmB for a severely obese patient with C albidus meningitis.
View Article and Find Full Text PDF[Cryptococcus albidus, Naganishia albida, primary skin infection, first case reported in Mexico].
Rev Med Inst Mex Seguro Soc
March 2025
Instituto Mexicano del Seguro Social, Centro Médico Nacional La Raza, Hospital de Especialidades "Dr. Antonio Fraga Mouret", Servicio de Infectología. Ciudad de México, México.
Background: The increase in immunosuppressive treatments and diseases that affect cellular immunity, such as diabetes, renal disease, and oncological or rheumatological conditions, has led to a rise in infections caused by opportunistic microorganisms. The aim of this work is to identify Naganishia albida as an infectious pathogen in immunocompromised patients, highlighting its importance and clinical evolution.
Clinical Case: One of the first identified cases of Naganishia albida is reported in a patient with immunosuppression secondary to oncological treatment, with domestic activity exposure being the main risk factor.
Cryptococcus albidus fungemia and probable meningitis in very preterm newborn: a case report and review of the literature.
BMC Pediatr
April 2025
Department of Pediatric-Infectious Diseases, King Abdulaziz Hospital, Almahjar Street, Jeddah, 22425, Saudi Arabia.
Background: In pediatric and neonatal age groups, infections from non-neoformans Cryptococcus species, notably Cryptococcus albidus, are rarely encountered. C. albidus is an emerging fungal pathogen that causes severe diseases in immunosuppressed patients; furthermore, it has rarely been reported to cause diseases in immunocompetent patients.
View Article and Find Full Text PDFThe Skin Mycobiome of Patients With Atopic Dermatitis and Healthy Volunteers: A Case-Control Study.
Exp Dermatol
March 2025
Department of Medical Microbiology, Institute of Microbiology, Faculty of Biology, University of Warsaw, Warsaw, Poland.
Atopic dermatitis (AD) is a common inflammatory skin disease, for which dysbiosis of the skin mycobiome is considered a triggering factor. The aim of this study was to explore the skin mycobiome of AD patients and healthy volunteers (HV). The study included 50 AD patients and as many HV.
View Article and Find Full Text PDF